Review

Asian Journal of Andrology (2007) 9, 3–7; doi:10.1111/j.1745-7262.2007.00232.x

Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors

Kenneth Jacobsohn and Run Wang

Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA

Correspondence: Run Wang, MD, FACS, Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA. Fax: +1-713-500-7319. E-mail: Run.Wang@uth.tmc.edu

Received 24 April 2006; Accepted 30 July 2006.

Top

Abstract

The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might require more invasive testing to diagnose and treat the specific cause of their dysfunction. This review looks at the tests and strategies available for men who cannot be treated by oral therapy alone.

Keywords:

erectile dysfunction, testing, treatment, diagnosis, phosphodiesterase type 5 inhibitors

Top

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61. | PubMed | ISI | ChemPort |
  2. Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: report of the nomenclature committee of the International Society of Impotence Research. Int J Imp Res 1999; 11: 141–3. | Article | ChemPort |
  3. Aversa A, Bruzziches R, Spera G. Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited. Int J Androl 2005; 28 (Suppl 2): 61–3. | Article | PubMed | ISI |
  4. Monatgue DK, Jarow JP, Roderick A, Dmochowski RR, Heaton JP, Lue TF, et al. Chapter 1: the management of erectile dysfunction: an AUA update. J Urol 2005; 174: 130–9.
  5. Lobo JR, Nehra A. Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors. Urol Clin N A 2005; 32: 447–55. | Article |
  6. Aversa A, Isidori AM, Caprio M, Cerilli M, Frajese V, Fabri A. Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuaracy and specificity. Int J Androl 2002; 25: 6–10. | Article | PubMed |
  7. McMahon CG. Correlation of penile Duplex ultrasonography, PBI, DICC and angiography in the diagnosis of impotence. Int J Imp Res 1998; 10: 153–8. | Article | ChemPort |
  8. Mancini M, Barolini M, Maggi M, Innocenti P, Villari N, Forti G. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl 2000; 23: 199–204. | Article | PubMed | ISI | ChemPort |
  9. Roy C, Saussine C, Tuchmann C, Castel E, Lang J, Jacqmin D. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound 2000; 28: 290–4. | Article | PubMed | ISI | ChemPort |
  10. Altinkilic B, Hauck EW, Weidner W. Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction. World J Urol 2004; 23: 361–4. | Article |
  11. Shah SR, Lee U, Bruce J, Lewis RW. Repeat dosing when performing color duplex Doppler ultrasonography: The MCG experience. J Sex Med 2004; 1 (Suppl 1): 71 abstract MP35.
  12. Montorsi F, Guazzoni G, Barbeiri L, Ferini-Strambi L, Iannaccone S, Calori G, et al. Genital plus audiovisual sexual stimulation following intracavernous vasoactive injection versus re-dosing for erectile dysfunction-results of a prospective study. J Urol 1998; 159: 113–5. | Article | PubMed | ISI | ChemPort |
  13. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol 2004; 58: 514–23. | Article |
  14. Granata A, Bancroft J, Del Rio G. Stress and the erectile resonse to intracavernosal prostaglandin E1 in men with erectile dysfunction. Psychosom Med 1995; 57: 336–44. | PubMed | ChemPort |
  15. Basar MM, Batislam E, Altinok D, Yilmaz E, Basar H. Sildeafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in doppler ultrasound evaluation of erectile dysfunction. Urology 2001; 57: 623–6. | Article | PubMed |
  16. Aversa A. Bertucci B, Bonifaio V, Isidori A, Fabbri A. The use of dynamic Doppler color ultrasonography of the penis in the study of erectile dysfunction. Rodiologi Medica 1999; 97: 499–505. | ChemPort |
  17. Wang R, Dang M, Stage AC, Chen PC. Does penile color duplex doppler ultrasound influence the decision for penile prosthesis implantation? J Sex Med 2006; 3 (Suppl 2): 153.
  18. Wang R, Chaves JM, Jacobsohn KM. Erect penile length induced by intracavernosal injection versus that obtained with penile prosthesis. J Sex Med 2006; 3 (Suppl 2): 154.
  19. Mulhall JP, Anderson M, Parker M. Congruence between veno-occlusive parameters during dynamic infusion cavernosometry: assessing the need for cavernosography. Int J Imp Res 2004; 16: 146–9. | Article | ChemPort |
  20. Jiang X, Frantzen J, Holsheimer J, Wagner G, Wijkstra H, Meuleman E. Reproducibility of corpus cavernosum electromyography. J Sex Med 2006; 3 (Suppl 1): 33 abstract 63.
  21. Jiang X, Frantzen J, Holsheimer J, Wagner G, Wijkstra H, Meuleman E. Corpus cavernosum electromyography in patients with penile fibrosis and patients who underwent pelvic surgery. J Sex Med 2006; 3 (Suppl 1): 34 abstract 64.
  22. Jiang X, Frantzen J, Holsheimer J, Wagner G, Wijkstra H, Meuleman E. Corpus cavernosum electromyography in patients with vasculogenic erectile dysfunction. J Sex Med 2006; 3 (Suppl 1): 34 abstract 65.

Extra navigation

.

naturejobs

More science jobs
Post a job for free
ADVERTISEMENT